Table 2.
Aprt mutationb | clones w/LOHc | total LOH eventsd |
---|---|---|
Non-mutant (NM) | 0/23 (0%) | 0/252 (0%) |
Chromosome loss (CL) | 15/39 (38%) | 28/428 (6.5%) |
Mitotic recombination (MR) | 3/23 (13%) | 4/253 (1.6%) |
Intragenic event (IE) | 2/25 (8%) | 4/275 (1.5%) |
Statistical comparison (p values)e | ||
NM vs. CL | <0.001 | <0.001 |
MR vs. CL | 0.032 | 0.003 |
IE vs. CL | 0.006 | 0.001 |
NM vs. MR | 0.155 | 0.109 |
NM vs. IE | 0.358 | 0.121 |
MR vs. IE | 0.721 | 1.000 |
One polymorphic locus for each of 11 additional chromosomes (2, 3, 5, 6, 7, 9, 11, 12, 13, 14, and 15) was examined for LOH.
The mutational event on chromosome 8 that led to loss of Aprt expression in mutant clones; non-mutant clones were isolated, without selection, from mouse kidneys.
The number of clones with one of more LOH events divided by the number of clones examined.
The number of loci exhibiting LOH divided by the number of loci examined. Data from chromosome 8 are excluded.
Statistical comparisons using exact unconditional test. Significant differences are bolded.